• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Lexicon Pharmaceuticals Inc

+ Add to Watchlist

LX3:GR

1.115 EUR 0.043 3.71%

As of 03:08:44 ET on 07/25/2014.

Snapshot for Lexicon Pharmaceuticals Inc (LX3)

Open: 1.115 Day's Range: 1.114 - 1.158 Volume: 0
Previous Close: 1.158 52wk Range: 0.909 - 2.277 1-Yr Rtn: -38.30%

Stock Chart for LX3

No chart data available.
  • LX3:GR 1.114
  • 1D
  • 1M
  • 1Y
1.158
Interactive LX3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LX3

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1890
Est. PEG Ratio -
Market Cap (M EUR) 574.16
Shares Outstanding (M) 514.94
30 Day Average Volume 2,190
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LX3

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LX3

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches treatments for diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders, and ophthalmic disease.

Lonnel CoatsPresident/CEOJeffrey L WadeExec VP:Corporate Dev/CFO
Brian P ZambrowiczExec VP/Chief Scientific OfcrPablo LapuertaExec VP:Clinical Dev
More Company Profile & Key Executives for LX3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil